Protein A Antibody (Mouse mAb) [E20E21]

Application: Reactivity: staphylococcus aureus

Usage Information

Dilution
WB1:1000

Application
WB, ELISA

Reactivity
staphylococcus aureus

Source
Mouse Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
56 kDa

Datasheet & SDS

Biological Description

Specificity
Protein A Antibody (Mouse mAb) [E20E21] detects bacterial or recombinant Protein A.

Clone
E20E21

Synonym(s)
Immunoglobulin G-binding protein A, IgG-binding protein A, Staphylococcal protein A (SpA), spa

Background
Protein A (SpA) is a surface-anchored component of Staphylococcus aureus and functions as a central immune evasion molecule of the organism. The protein consists of a series of highly homologous three-helix-bundle immunoglobulin-binding domains that project outward from the cell wall, anchored through an X region and a sorting sequence embedded in the peptidoglycan. Each Ig-binding domain engages the Fc region of IgG at the CH2–CH3 interface through helices I and II, a site that overlaps with the epitope recognized by the neonatal Fc receptor FcRn, while helices II and III mediate parallel binding to the Fab region of antibodies bearing VH3-family heavy chains. Occupation of the CH2–CH3 interface by SpA sterically blocks IgG from engaging FcγRs on neutrophils and other phagocytes and, separately, obstructs FcRn recognition, thereby dismantling the two receptor systems that normally drive opsonophagocytic clearance. Beyond blocking Fc receptor engagement, SpA interferes with IgG hexamer assembly on the bacterial surface, a process required for efficient recruitment and activation of complement component C1, curtailing downstream complement-mediated opsonization and bacterial killing. The same IgG-binding domains extend SpA's reach beyond antibody sequestration: they engage TNFR1 on host cells, triggering chemokine expression and driving TNF-converting enzyme-dependent shedding of soluble TNFR1, a response that dampens local inflammatory signaling, particularly within pulmonary tissue. Substitutions within the conserved IgG-binding residues diminish both TNFR1 activation and Fc capture, tying the inflammatory and immune-evasive functions of SpA to a shared structural interface. The Ig-binding region also mediates SpA attachment to von Willebrand factor domains, linking the protein to platelet adhesion under shear stress and broadening its role in host-pathogen interaction beyond the immunoglobulin system.

Background

Protein A (SpA) is a surface-anchored component of Staphylococcus aureus and functions as a central immune evasion molecule of the organism. The protein consists of a series of highly homologous three-helix-bundle immunoglobulin-binding domains that project outward from the cell wall, anchored through an X region and a sorting sequence embedded in the peptidoglycan. Each Ig-binding domain engages the Fc region of IgG at the CH2–CH3 interface through helices I and II, a site that overlaps with the epitope recognized by the neonatal Fc receptor FcRn, while helices II and III mediate parallel binding to the Fab region of antibodies bearing VH3-family heavy chains. Occupation of the CH2–CH3 interface by SpA sterically blocks IgG from engaging FcγRs on neutrophils and other phagocytes and, separately, obstructs FcRn recognition, thereby dismantling the two receptor systems that normally drive opsonophagocytic clearance. Beyond blocking Fc receptor engagement, SpA interferes with IgG hexamer assembly on the bacterial surface, a process required for efficient recruitment and activation of complement component C1, curtailing downstream complement-mediated opsonization and bacterial killing. The same IgG-binding domains extend SpA's reach beyond antibody sequestration: they engage TNFR1 on host cells, triggering chemokine expression and driving TNF-converting enzyme-dependent shedding of soluble TNFR1, a response that dampens local inflammatory signaling, particularly within pulmonary tissue. Substitutions within the conserved IgG-binding residues diminish both TNFR1 activation and Fc capture, tying the inflammatory and immune-evasive functions of SpA to a shared structural interface. The Ig-binding region also mediates SpA attachment to von Willebrand factor domains, linking the protein to platelet adhesion under shear stress and broadening its role in host-pathogen interaction beyond the immunoglobulin system.

References
https://pubmed.ncbi.nlm.nih.gov/42574524/ https://pubmed.ncbi.nlm.nih.gov/16709567/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%